
SGD Pharma is proud to announce the conversion of one of our two high-efficiency furnaces at our Saint-Quentin-Lamotte (SQLM) manufacturing facility in France. This conversion is part of our ambitious global decarbonisation strategy and will help reduce our overall carbon emissions by two-thirds by 2040.
